Promoting Breastfeeding and Interaction of Pediatric Associations With Providers of Nutritional Products

Frontiers in Pediatrics

Delane Shingadia¹  Pierre Tissieres²  Luigi Titomanlio³  Rezan Topaloglu⁴  Johannes Trück⁵  Magnus Domellöf⁶  Berthold Koletzko⁷  Adamos Hadjipanayis⁸  Sanja Kolacek⁹  Dieter Haffner^1,10  Miguel Saenz de Pipaon^1,11  Mark Johnson^1,12  Daniele De Luca^1,13  Zsolt Bognar^1,14 

[1] 0European Society for Paediatric Infectious Diseases (ESPID), Institute of Child Health, University College London, Great Ormond Street Hospital, London, United Kingdom;1European Society of Paediatric and Neonatal Intensive Care, Paediatric and Neonatal Intensive Care Unit, Paris Saclay University Hospitals-APHP, Le Kremlin-Bicêtre, France;2Pediatric Section of the European Society of Emergency Medicine (EUSEM), Pediatric Emergency Department and Migraine and Neurovascular Diseases Clinic, INSERM U1141—Paris University, Robert Debré Hospital, Paris, France;3European Society for Paediatric Nephrology (ESPN), Department Pediatric Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkey;4European Society for Paediatric Infectious Diseases (ESPID), University Children's Hospital Zurich, Zurich, Switzerland;Chair Nutrition Committee, European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), Department of Clinical Sciences, Umeå University, Umeå, Sweden;European Academy of Paediatrics (EAP), Department of Paediatrics, University Hospital LMU Munich, Dr. von Hauner Children's Hospital, LMU-Ludwig-MaximiliansUniversität München, Munich, Germany;European Academy of Paediatrics (EAP), European University Cyprus, Paediatric Department, Larnaca General Hospital, Larnaca, Cyprus;European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), University Department of Paediatrics, Children's Hospital Zagreb, Zagreb, Croatia;European Society for Paediatric Nephrology (ESPN), Department of Paediatric Kidney, Liver and Metabolic Diseases, Children's Hospital, Hannover Medical School, Hanover, Germany;European Society for Paediatric Research (ESPR), Department of Pediatrics, Hospital Universitario La Paz, Universidad Autónoma de Madrid, Madrid, Spain;European Society for Paediatric Research (ESPR), National Institute for Health Research, Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust and University of Southampton, Southampton, United Kingdom;European Society of Paediatric and Neonatal Intensive Care, Paris Saclay University Hospitals-APHP, Medical Center A. Beclere, Clamart, France;Pediatric Section of the European Society of Emergency Medicine (EUSEM), Paediatric Emergency Department, Heim Pal National Paediatric Institute, Budapest, Hungary;

关键词: continuing medical education;    infant nutrition;    infant and young child feeding;    public private sector cooperation;    privately sponsored programs;   

DOI  :  10.3389/fped.2020.562870

来源: DOAJ

【 摘 要 】

Pediatric associations have been urged not to interact with and not to accept support from commercial providers of breast milk substitutes (BMSs), based on the assumption that such interaction would lead to diminished promotion and support of breastfeeding. The leadership of seven European pediatric learned societies reviewed the issue and share their position and policy conclusions here. We consider breastfeeding as the best way of infant feeding and strongly encourage its active promotion, protection, and support. We support the World Health Organization (WHO) Code of Marketing of BMSs. Infant formula and follow-on formula for older infants should not be advertised to families or the public, to avoid undermining breastfeeding. With consistently restricted marketing of BMSs, families need counseling on infant feeding choices by well-informed pediatricians. Current and trustworthy information is shared through congresses and other medical education directed and supervised by independent pediatric organizations or public bodies. Financial support from commercial organizations for congresses, educational, and scientific activities of pediatric organizations is an acceptable option if scientific, ethical, societal, and legal standards are followed; any influence of commercial organizations on the program is excluded, and transparency is ensured. Public–private research collaborations for improving and evaluating pharmaceuticals, vaccines, medical devices, dietetic products, and other products and services for children are actively encouraged, provided they are guided by the goal of enhancing child health and are performed following established high standards. We support increasing investment of public funding for research aiming at promoting child health, as well as for medical education.

【 授权许可】

Unknown